Items Tagged ‘Lou Gehrig’s disease’
September 21, 2022
Maintaining quality care for patients with ALS — Lessons from the pandemic
By Advancing the Science contributor 
By Susan Barber Lindquist The efficiency and effectiveness of telemedicine exploded during the COVID-19 pandemic. For patients with Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis or ALS, telemedicine always has been an important piece of their medical care. A recent study in Neurology by Mayo Clinic researchers offers one more proof point. Tests […]
Tags: ALS, amyotrophic lateral sclerosis, clinical trials, COVID-19, Lou Gehrig's disease, Nathan Staff, neurology, remote patient monitoring, telehealth, telemedicine
May 24, 2021
How regenerative medicine is advancing ALS research
May is ALS Awareness Month, a time to reflect on the role of regenerative medicine research in advancing understanding and treatment of amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease. This neurodegenerative disorder causes nerve cells in the brain and spinal cord to die, blocking signals to the muscles. That results in paralysis that robs […]
Tags: ALS, amyotrophic lateral sclerosis, Anthony Windebank, Center for Regenerative Medicine, Lou Gehrig's disease, medical research, Nathan Staff
February 5, 2020
“I Just Didn’t Understand”: On a Mission to Cure ALS
By Advancing the Science contributor
By Barbara J. Toman For Veronique Belzil, Ph.D., the fight against amyotrophic lateral sclerosis (ALS) is personal. In 2000, while working as a psychologist in Canada, she watched her husband’s uncle succumb to the disease. “The progression was so fast and his condition was so sad,” she says. “I just didn’t understand how this could […]
Tags: ALS, amyotrophic lateral sclerosis, Center for Individualized Medicine, DNA, epigenetics, Lou Gehrig's disease, Veronique Belzil
January 2, 2019
Toward clinical trials for one type of ALS
By Kate Ledger
When a team of Mayo Clinic researchers discovered in 2011 the genetic repeat mutation known as c9orf72, the finding shed new light on amyotrophic lateral sclerosis (ALS). The mutation, which occurs as a short sequence of code repeated hundreds to thousands of times in the gene, is now known to appear in 40 percent of […]
Tags: ALS, amyotrophic lateral sclerosis, Björn Oskarsson, clinical trials, Dennis Dickson, Kevin Boylan, Leonard Petrucelli, Lou Gehrig's disease, neurology, neurosciences, Rosa Rademakers, Tania Gendron
January 5, 2015
The Next Generation of Biomedical Researchers: Torn by Irresistible Forces
Hours of study, lectures to attend, research to complete, labs to monitor, data to analyze, papers to write, new solutions to old problems to noodle on. It’s just another day in the life of a biomedical research student. The to-do list never seems to end. Morning to night, seven days a week. The path to […]
Tags: ALS, biomedical research, Jim Maher, Lou Gehrig's disease, Mayo Clinic Graduate School of Biomedical Sciences, neurology, regenerative medicine, research education